ISDA

Deposition Date 2019-10-16

Release Date 2019-12-25

Last Version Date 2024-11-13

Entry Detail

PDB ID:

5QTU

Keywords:

HYDROLASE/HYDROLASE inhibitor

Title:

FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli BL21(DE3)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.53 Å

R-Value Free:

0.23

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 32 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Coagulation factor XI
Gene (Uniprot):F11
Chain IDs:A
Chain Length:244
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P03951 Pfam ID:PF00089 EC:3.4.21.27

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Coagulation factor XI
Gene (Uniprot):F11
Chain IDs:B (auth: H)
Chain Length:18
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P03951 Pfam ID:PF00089 EC:3.4.21.27

Ligand Molecules

EDO

QEV

SO4

Primary Citation

Potent, Orally Bioavailable and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups.

Corte, J.R, Pinto, D.J.P, Fang, T, Osuna, H, Yang, W, Wang, Y, Lai, A, Clark, C, Sun, J.H, Rampulla, R.A, Mathur, A, Kaspady, M, Neithnadka, P.R, Li, Y.X, Rossi, K.A, Myers, J.E, Sheriff, S, Lou, Z, Harper, T.W, Huang, C.S, Zheng, J.J, Bozarth, J.M, Wu, Y, Wong, P.C, Crain, E, Seiffert, D.A, Luettgen, J.M, Lam, P, Wexler, R.R, Ewing, W.R, Quan, M.L, Wong, P.C, Wang, C, Woerner, F, Smallheer, J.M, Barbera, F.A, Bozarth, J.M, Brown, R.L, Harpel, M.R, Luettgen, J.M, Morin, P.E, Peterson, T, Ramamurthy, V, Rendina, A.R, Rossi, K.A, Watson, C.A, Wei, A, Zhang, G, Seiffert, D, Wexler, R.R, Hangeland, J.J, Friends, T.J, Rossi, K.A, Smallheer, J.M, Wang, C, Sun, Z, Corte, J.R, Fang, T, Wong, P.C, Rendina, A.R, Barbera, F.A, Bozarth, J.M, Luettgen, J.M, Watson, C.A, Zhang, G, Wei, A, Ramamurthy, V, Morin, P.E, Bisacchi, G.S, Subramaniam, S, Arunachalam, P, Mathur, A, Seiffert, D.A, Wexler, R.R, Quan, M.L, Corte, J.R, Fang, T, Hangeland, J.J, Friends, T.J, Rendina, A.R, Luettgen, J.M, Bozarth, J.M, Barbera, F.A, Rossi, K.A, Wei, A, Ramamurthy, V, Morin, P.E, Seiffert, D.A, Wexler, R.R, Quan, M.L, Pinto, D.J, Smallheer, J.M, Corte, J.R, Austin, E.J, Wang, C, Fang, T, Smith 2nd, L.M, Rossi, K.A, Rendina, A.R, Bozarth, J.M, Zhang, G, Wei, A, Ramamurthy, V, Sheriff, S, Myers Jr, J.E, Morin, P.E, Luettgen, J.M, Seiffert, D.A, Quan, M.L, Wexler, R.R, Hu, Z, Wong, P.C, Gilligan, P.J, Han, W, Pabbisetty, K.B, Bozarth, J.M, Crain, E.J, Harper, T, Luettgen, J.M, Myers Jr, J.E, Ramamurthy, V, Rossi, K.A, Sheriff, S, Watson, C.A, Wei, A, Zheng, J.J, Seiffert, D.A, Wexler, R.R, Quan, M.L, Smith 2nd, L.M, Orwat, M.J, Hu, Z, Han, W, Wang, C, Rossi, K.A, Gilligan, P.J, Pabbisetty, K.B, Osuna, H, Corte, J.R, Rendina, A.R, Luettgen, J.M, Wong, P.C, Narayanan, R, Harper, T.W, Bozarth, J.M, Crain, E.J, Wei, A, Ramamurthy, V, Morin, P.E, Xin, B, Zheng, J, Seiffert, D.A, Quan, M.L, Lam, P.Y.S, Wexler, R.R, Pinto, D.J.P, Corte, J.R, Fang, T, Pinto, D.J, Orwat, M.J, Rendina, A.R, Luettgen, J.M, Rossi, K.A, Wei, A, Ramamurthy, V, Myers Jr, J.E, Sheriff, S, Narayanan, R, Harper, T.W, Zheng, J.J, Li, Y.X, Seiffert, D.A, Wexler, R.R, Quan, M.L, Corte, J.R, Fang, T, Osuna, H, Pinto, D.J, Rossi, K.A, Myers Jr, J.E, Sheriff, S, Lou, Z, Zheng, J.J, Harper, T.W, Bozarth, J.M, Wu, Y, Luettgen, J.M, Seiffert, D.A, Decicco, C.P, Wexler, R.R, Quan, M.L, Corte, J.R, Yang, W, Fang, T, Wang, Y, Osuna, H, Lai, A, Ewing, W.R, Rossi, K.A, Myers Jr, J.E, Sheriff, S, Lou, Z, Zheng, J.J, Harper, T.W, Bozarth, J.M, Wu, Y, Luettgen, J.M, Seiffert, D.A, Quan, M.L, Wexler, R.R, Lam, P.Y.S, Wang, C, Corte, J.R, Rossi, K.A, Bozarth, J.M, Wu, Y, Sheriff, S, Myers Jr, J.E, Luettgen, J.M, Seiffert, D.A, Wexler, R.R, Quan, M.L, Pinto, D.J.P, Orwat, M.J, Smith 2nd, L.M, Quan, M.L, Lam, P.Y.S, Rossi, K.A, Apedo, A, Bozarth, J.M, Wu, Y, Zheng, J.J, Xin, B, Toussaint, N, Stetsko, P, Gudmundsson, O, Maxwell, B, Crain, E.J, Wong, P.C, Lou, Z, Harper, T.W, Chacko, S.A, Myers Jr, J.E, Sheriff, S, Zhang, H, Hou, X, Mathur, A, Seiffert, D.A, Wexler, R.R, Luettgen, J.M, Ewing, W.R, Clark, C.G, Rossi, K.A, Corte, J.R, Fang, T, Smallheer, J.M, De Lucca, I, Nirschl, D.S, Orwat, M.J, Pinto, D.J.P, Hu, Z, Wang, Y, Yang, W, Jeon, Y, Ewing, W.R, Myers Jr, J.E, Sheriff, S, Lou, Z, Bozarth, J.M, Wu, Y, Rendina, A, Harper, T, Zheng, J, Xin, B, Xiang, Q, Luettgen, J.M, Seiffert, D.A, Wexler, R.R, Lam, P.Y.S, Fang, T, Corte, J.R, Gilligan, P.J, Jeon, Y, Osuna, H, Rossi, K.A, Myers Jr, J.E, Sheriff, S, Lou, Z, Zheng, J.J, Harper, T.W, Bozarth, J.M, Wu, Y, Luettgen, J.M, Seiffert, D.A, Wexler, R.R, Lam, P.Y.S.Show

J.Med.Chem. 63 784 803 (2019)

PMID: 31833761 DOI: 10.1021/acs.jmedchem.9b01768

Abstact

Factor XIa (FXIa) inhibitors are promising novel anticoagulants, which show excellent efficacy in preclinical thrombosis models with minimal effects on hemostasis. The discovery of potent and selective FXIa inhibitors which are also orally bioavailable has been a challenge. Here, we describe optimization of the imidazole-based macrocyclic series and our initial progress toward meeting this challenge. A two-pronged strategy, which focused on replacement of the imidazole scaffold and the design of new P1 groups, led to the discovery of potent, orally bioavailable pyridine-based macrocyclic FXIa inhibitors. Moreover, pyridine-based macrocycle 19, possessing the phenylimidazole carboxamide P1, exhibited excellent selectivity against relevant blood coagulation enzymes and displayed antithrombotic efficacy in a rabbit thrombosis model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures